The Life Spectrum of Asthma Online: Reducing and/or Eliminating Asthma Exacerbations

This module describes which factors are important in producing exacerbations and how they can be both treated acutely and prevented in the future.

There are four talks in this module. You can view or download the videos or audio along with the presentation handouts from the following pages.

Talk 1: Identifying Biologic Targets to Attenuate or Eliminate Asthma Exacerbations
            William W. Busse, MD FAAAAI

Talk 2: Immunopathologic Features of Asthma Exacerbations
        
    Mario Castro, MD MPH 

Talk 3: Acute Physiologic Characteristics and Long Term Clinical Consequences of Asthma Exacerbations
            Stephen P. Peters, MD PhD FAAAAI

Talk 4: Precision Asthma Therapy: Picking the Right Biologic for the Right Patient
            Thomas B. Casale, MD FAAAAI

Click here to view faculty responses to audience questions asked during the talks.

The Life Spectrum of Asthma: Online is funded through an educational grant from GlaxoSmithKline.

Target Audience

  • Allergist/Immunologists
  • Fellows-in-Training 
  • Allied Health providers 

Learning Objectives

Upon completion of this activity, learners should be able to:

  • Describe the biological characteristics of asthma exacerbations 
  • Outline the appropriate use of biologic therapies to treat asthma exacerbations
Summary
Available credit: 
  • 2.00 Attendance
    Attendance credit.
  • 2.00 CME
    CME credit.
Course opens: 
10/03/2016
Course expires: 
10/02/2018
Member cost:
$60.00
Cost:
$75.00
Rating: 
0

Faculty members and disclosures will be listed with each talk.

Moderator
Jacqueline A. Pongracic, MD FAAAAI
Ann and Robert H. Lurie Children’s Hospital of Chicago
Relevant relationships: None

Planning Committee
Thomas B. Casale, MD FAAAAI
University of South Florida
Relevant relationships: Sanofi-Regeneron, Teva, Novartis, Genentech, Boehringer Ingelheim, AstraZeneca (advisory board); Allerquest, Circassia, Capnia (consultant); Parexel (honorarium)

Robert F. Lemanske, Jr., MD FAAAAI
University of Wisconsin 
Relevant relationships: Pharmaxis (research funding) 

CME Committee Reviewers
Kim E. Mudd, RN MSN CCRP
Johns Hopkins University, Baltimore, MD
Relevant relationships: None

Kevin W. Parks, MD FAAAAI
AAC/CRI of Southern Oregon, Medford, OR 
Relevant relationships: None

Available Credit

  • 2.00 Attendance
    Attendance credit.
  • 2.00 CME
    CME credit.

Accreditation Period

Course opens: 
10/03/2016
Course expires: 
10/02/2018

Price

Member cost:
$60.00
Cost:
$75.00
Please login or register to take this course.

Required Hardware/software

Required hardware / software
One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.

Internet Explorer is not supported.